Current Regulatory Status and What to Expect from the MHRA Retatrutide is not approved by the MHRA, EMA, or FDA and remains available only within authorised clinical trials
The most common side effects of Wegovy are: headache feeling or being sick constipation diarrhoea stomach pain weakness or tiredness These effects are most likely to occur when you first start treatment or when you increase your dose of the medication
They also contain 5 billion colony-forming units (CFU) of the probiotic Bacillus subtilis (MB40), which may help reduce bloating
Full report: To view or add a comment, sign in More Relevant Posts Read EY Australia's latest research on how GLP-1 is impacting consumer choices and what implications this might have on your categories
Glucagon-like peptide 1 agonists (GLP-1) and Gastric inhibitory polypeptide (GIP) have emerged as valuable therapeutic agents for managing obesity and type 2 diabetes
You inject once weekly, and the medication maintains therapeutic effects throughout that full week